14729-D9831C00002- 1 month Biopsy study - Biopsy

Study identifier:D9831C00002

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A double-blind, placebo-controlled, randomised, parallel group phase IIa study to evaluate the histological changes, cellularity, clinical efficacy and safety of AZD1981 in patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD)

Medical condition

Chronic Obstructive Pulmonary Disease

Phase

Phase 2

Healthy volunteers

No

Study drug

AZD1981, Placebo

Sex

All

Actual Enrollment

52

Study type

Interventional

Age

40 Years +

Date

Study Start Date: 01 Nov 2008
Primary Completion Date: -
Study Completion Date: 01 Jun 2009

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Oct 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria